COSCIENS Biopharma Inc. (TSX:CSCI)
Canada · Delayed Price · Currency is CAD 2.690
-0.190 (-6.60%)
May 29, 2026, 3:59 PM EST
COSCIENS Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 4.05 | -10.36 | -15.31 | -3.49 | 3.45 | -8.37 |
Depreciation & Amortization | 1.2 | 1.19 | 1.61 | 1.44 | 1.47 | 0.15 |
Loss (Gain) From Sale of Assets | -11.29 | - | - | - | - | -0 |
Asset Writedown & Restructuring Costs | 0.24 | 0.24 | 4.26 | - | - | - |
Stock-Based Compensation | -0.02 | -0.01 | 0.46 | 0.19 | 0.07 | 0.31 |
Other Operating Activities | -0.51 | 0.18 | -3.07 | -0.79 | 1.18 | -3.17 |
Change in Accounts Receivable | -0.97 | 1.15 | -1.68 | 1.86 | -0.61 | 0.12 |
Change in Inventory | 1.31 | 1.42 | 1.11 | -1.16 | -1.09 | -0.06 |
Change in Accounts Payable | -3.1 | -2.45 | -0.82 | -0.42 | 0.81 | 0.63 |
Change in Unearned Revenue | -0 | 0.01 | 0.22 | - | - | 3.01 |
Change in Income Taxes | - | - | - | - | - | -0.11 |
Change in Other Net Operating Assets | 0.31 | 0.17 | -0.59 | -0.13 | 0.02 | -1.1 |
Operating Cash Flow | -8.77 | -8.47 | -14.57 | -2.58 | 5.23 | -8.58 |
Capital Expenditures | -0.09 | -0.71 | -1.16 | -0.72 | -0.3 | -0.03 |
Sale of Property, Plant & Equipment | 0.25 | 0.24 | - | - | - | 0 |
Cash Acquisitions | - | - | 26.04 | - | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | - | -0.61 |
Other Investing Activities | 0.01 | 0 | 0.21 | -0.01 | - | -0.02 |
Investing Cash Flow | 0.13 | -0.46 | 25.08 | -0.73 | -0.3 | -0.66 |
Long-Term Debt Repaid | - | -0.37 | -0.42 | -0.37 | -0.33 | -0.13 |
Net Debt Issued (Repaid) | -0.25 | -0.37 | -0.42 | -0.37 | -0.33 | -0.13 |
Issuance of Common Stock | - | - | - | 0.01 | 0.06 | 54.29 |
Other Financing Activities | -0.04 | -0.04 | -0.17 | - | - | -3.12 |
Financing Cash Flow | -0.29 | -0.41 | -0.59 | -0.36 | -0.27 | 51.04 |
Foreign Exchange Rate Adjustments | 0.17 | 0.25 | -0.21 | 0.16 | -0.63 | -0.77 |
Net Cash Flow | -8.75 | -9.09 | 9.72 | -3.51 | 4.03 | 41.03 |
Free Cash Flow | -8.86 | -9.18 | -15.73 | -3.3 | 4.93 | -8.61 |
Free Cash Flow Margin | -110.80% | -122.42% | -164.07% | -46.26% | 33.80% | -163.71% |
Free Cash Flow Per Share | -2.80 | -2.90 | -6.09 | -1.79 | 2.66 | -7.49 |
Cash Income Tax Paid | - | - | - | - | - | 1.61 |
Levered Free Cash Flow | -7.42 | -6.32 | -2.44 | -7.7 | 3.78 | -4.75 |
Unlevered Free Cash Flow | -7.33 | -6.21 | -2.36 | -7.61 | 3.87 | -4.75 |
Change in Working Capital | -2.45 | 0.29 | -2.51 | 0.06 | -0.94 | 2.5 |